Total Payments
$375.65
2022 Payments
$77.18
Companies
5
Transactions
18
Medicare Patients
3,129
Medicare Billing
$407,575
Payment Breakdown by Category
Food & Beverage$375.65 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $375.65 | 18 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $143.39 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $142.81 | 9 | $0 (2022) |
| Chiesi USA, Inc. | $36.91 | 2 | $0 (2022) |
| PFIZER INC. | $27.26 | 2 | $0 (2018) |
| Allergan Inc. | $25.28 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $77.18 | 4 | Janssen Pharmaceuticals, Inc ($40.27) |
| 2021 | $28.43 | 2 | Janssen Pharmaceuticals, Inc ($28.43) |
| 2020 | $14.45 | 1 | Janssen Pharmaceuticals, Inc ($14.45) |
| 2019 | $59.66 | 4 | Janssen Pharmaceuticals, Inc ($59.66) |
| 2018 | $149.29 | 3 | Relypsa, Inc. ($122.03) |
| 2017 | $46.64 | 4 | Allergan Inc. ($25.28) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/13/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/09/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/27/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/27/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/27/2018 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $122.03 | General |
| Category: Hyperkalemia | ||||||
| 01/10/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/13/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/21/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Hyperkalemia | ||||||
| 02/17/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: Hyperkalemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 586 | 597 | $912,034 | $72,175 |
| 2022 | 4 | 738 | 757 | $1.2M | $97,426 |
| 2021 | 5 | 845 | 868 | $1.3M | $109,982 |
| 2020 | 6 | 960 | 999 | $1.5M | $127,992 |
Total Patients
3,129
Total Services
3,221
Medicare Billing
$407,575
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 336 | 344 | $581,907 | $46,589 | 8.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 173 | 175 | $187,233 | $15,745 | 8.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 52 | 53 | $126,022 | $8,590 | 6.8% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 25 | 25 | $16,872 | $1,251 | 7.4% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 525 | 542 | $914,896 | $76,581 | 8.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 102 | 102 | $107,406 | $9,228 | 8.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 45 | 46 | $108,698 | $7,878 | 7.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 66 | 67 | $43,818 | $3,739 | 8.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 551 | 572 | $965,536 | $81,370 | 8.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 133 | 135 | $142,155 | $12,978 | 9.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 50 | 50 | $118,150 | $8,589 | 7.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 99 | 99 | $64,746 | $5,635 | 8.7% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 12 | 12 | $12,168 | $1,411 | 11.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 650 | 684 | $1.1M | $95,689 | 8.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 66 | 67 | $158,013 | $12,045 | 7.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 118 | 120 | $125,675 | $11,242 | 8.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 83 | 84 | $54,681 | $4,257 | 7.8% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 32 | 33 | $33,330 | $3,976 | 11.9% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 11 | 11 | $15,378 | $782.98 | 5.1% |
About Dr. Eric Romig, MD
Dr. Eric Romig, MD is a Emergency Medicine healthcare provider based in Natchez, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528004652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Romig, MD has received a total of $375.65 in payments from pharmaceutical and medical device companies, with $77.18 received in 2022. These payments were reported across 18 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($375.65).
As a Medicare-enrolled provider, Romig has provided services to 3,129 Medicare beneficiaries, totaling 3,221 services with total Medicare billing of $407,575. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Natchez, MS
- Active Since 06/20/2006
- Last Updated 07/08/2007
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1528004652
Products in Payments
- Veltassa (Drug) $143.39
- XARELTO (Drug) $142.81
- CLEVIPREX (Drug) $36.91
- ELIQUIS (Drug) $27.26
- DALVANCE (Drug) $14.27
- TEFLARO (Drug) $11.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.